¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sponge divers disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • Owren¡¯s disease
    ¿Àºê·»º´
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • Pick disease
    ÇȺ´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°ÀÚº´
  • pandemic disease
    ¹üÀ¯Çິ
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸Óº´
  • polycystic kidney disease
    ´Ù³¶½ÅÀ庴, ¹µÁÖ¸Ó´ÏÄáÆÏº´
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ²ÇÁ¼¼Æ÷Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • professional disease
    Àü¹®Á÷¾÷º´, Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • pulseless disease
    ¹«¸Æ¹Úº´, ¹«¸Æº´
  • pyramidal disease
    ÇǶó¹Ô½Å°æ·Îº´, Ãßü½Å°æ·Îº´
  • quarantinable disease
    °Ë¿ªÁúȯ
  • rat-bite disease
    Áã¹°±âº´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
  • respiratory disease
    È£Èí±âº´
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    (¢¡beriberi) °¢±â
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • rolling disease
    ÀüÀüº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ
  • granulomatous disease of childhood
    ¼Ò¾ÆÀ°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease of childhood
    ¼Ò¾Æ À°¾ÆÁ¾¼º Áúȯ
  • graves disease
    ±×·¹À̺꽺 º´, Grave º´
  • grinder s disease ; silicosis
    ±ÔÆóÁõ, ºÐ¼â±â°øº´.
  • grinder s disease ; silicosis
    ±ÔÆóÁõ.
  • hallervoden-spatz disease
    ÇÒ·¯º¸µç-½´ÆÄÂê º´, Hallervoden-Spatz º´
  • hand and foot disease
    ¼ö Á· Áúȯ£¨â¢ðëòðü´£©£¬¼Õ ¹ß º´, ¼ö Á· º´ (â¢ðëÜ»).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ).
  • hand foot and mouth disease
    ¼Õ¹ßÀÔº´ (¡­Ü»), ¼öÁ·±¸º´(â¢ðëϢܻ)
  • hand-foot-mouth disease
    ¼öÁ·±¸º´
  • hand-schueller-christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÂùº´
  • hanseniasis = Hansens disease
    ÇѼ¾º´
  • hansens disease
    ÇѼ¾ º´, Hansen º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • disease
    Áúº´(Ü»), Áúȯ(òðü´)
  • disease
    º´, Áúº´, Áúȯ
  • disease
    º´(Ü»), Áúº´(òðÜ»), Áúȯ(òðü´).
  • disease
    º´(ËÓ), Áúº´(̤ËÓ), Áúȯ(̷̤).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(Ü»êÂô÷ÜÁêóíº).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(ËÓËô̧ËÓËôËö).
  • disease control
    Áúº´°ü¸®.
  • disease detection
    Áúº´¹ß°ß.
  • disease entity
    Áúº´´ÜÀ§(òðܻӤêÈ).
  • disease entity
    Áúº´´ÜÀ§(̤ËÓËÀËô).
  • disease free interval
    ¹«º´±â°£
  • disease free survival
    ¹«º´»ýÁ¸
  • disease potential
    Áúº´ÀáÀç·Â.
  • disease prevention
    Áúº´¿¹¹æ(¡­çãÛÁ).
  • disease prevention
    Áúº´¿¹¹æ(ÊÙËçËÑ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
VD vapor density; vascular disease; vasodilation, vasodilator; venereal disease; venous dilatation; ven...
VHD valvular heart disease; viral hematodepressive disease
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
ALP ALkaline Phosphatase
  = AP
  »ó½Â
    1. Paget Dise...
BD Behcet's Disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
CWD Chronic wasting disease
CAD Cold agglutinin disease
CDSC Communicable Disease Surveillance Centre
CHD Congenital Heart Disease
CERAD Consortium To Establish a Registry for Alzheimer's Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
  • sexually transmitted disease
    ¼º Àü¿°¼º Áúȯ
    Åë»óÀûÀÎ ¼º±³¿¡ ÀÇÇÑ ¼ºº´À» Æ÷ÇÔÇÏ¿©, ¼º±³´Â ¾Æ´ÏÁö¸¸ À¯»çÇÑ ¼º ÇàÀ§·Î °¨¿°µÇ´Â ¸ðµç Áúȯ. ¼º¿¡ ´ëÇÑ »çȸ °ü½ÀÀº Áö³­ ¼ö ½Ê ³â¿¡ °ÉÃÄ ¸¹ÀÌ º¯È­ÇÏ¿´À¸¸ç, 1970³â´ë¿¡ À̸£·¯ ¼º ÇàÀ§ÀÇ ´Ù¾ç¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³µ´Ù. Áï, À̼º°£ÀÇ ¼º±³»Ó¸¸ ¾Æ´Ï¶ó µ¿¼º°£¿¡ ÇàÇÏ¿©Áö´Â ¿©·¯ ÇüÅÂÀÇ ¼º ÇàÀ§, ¿©·¯ »ó´ëÀÚ¿ÍÀÇ ¼º °ü°è, ´Ù¾çÇÑ ¼º ±â±³ ¹× ±¸°­ ¼º±â ¼º ÇàÀ§ µî ´Ù¾çÇØÁ³À¸¸ç, ÀÌ¿¡ µû¶ó °¨¿°ÀÇ Á¾·ùµµ Áõ°¡ÇÏ¿´´Ù. ¶ÇÇÑ °¨¿° °æ·Îµµ Åë»óÀû ¼º±³ ¿Ü¿¡ ±¸°­ ¹× ¼º±â¿¡ÀÇ ÀÔ¸ÂÃã¿¡ ÀÇÇÑ °æ±¸ °¨¿°, µ¿¼º¾Ö ³²¼º°£¿¡ ÇàÇÏ¿©Áö´Â Ç×¹® ¼º±³ ¹× ¿©·¯ »ç¶÷ÀÌ ¾î¿ï·Á ºÒ°áÇÏ°Ô À̺ÎÀÚ¸®¸¦ °°ÀÌ »ç¿ëÇÏ´Â µ¥¼­ ¿À´Â ±â»ýÃæ °¨¿° µî ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ¼º Àü¿°¼º ÁúȯÀ» ÀÏÀ¸Å°´Â º´¿øÃ¼µµ ´Ù¾çÇÏ¿©, ´ëº°ÇØ º¸¸é, ¼¼±Õ, ¹ÙÀÌ·¯½º, Ŭ¶ó¹Ìµð¾Æ Æ®¶óÄÚ¸¶Æ¼½º
  • silo-filler's disease
    »çÀÏ·Î Ãæ¸¸ °¡½ºº´
    ¶§¶§·Î ±Þ¼º Æó ºÎÁ¾À» ¼ö¹ÝÇÏ´Â ÆóÀÇ ¿°ÁõÀ¸·Î, »çÀϷο¡ ¸ðÀÎ Àڱؼº °¡½ºÀÇ ÈíÀÔÀÌ ¿øÀÎÀÌ´Ù.
  • Simmonds' disease
    ½Ã¸óµå º´, ½Ã¸óÁ
    1. ÇϼöüÀÇ À§ÃàÀ¸·Î ÀÎÇØ ±ØµµÀÇ ¼è¾à, ¼Ò¸ð, ¹× Á¤½Å Àå¾Ö¸¦ À¯¹ßÇϰí, Á¶·Î, Å»¸ð, ¼º¿å °¨Åð, ±âÃÊ ´ë»ç ÀúÇÏ µîÀ» Ư¡À¸·Î Çϴµ¥ ÁÖ·Î ¿©ÀÚ¿¡¼­ º¼ ¼ö ÀÖ´Ù. 2. somatotro
  • smith strang disease : ¸ÞŸÀÌ¿À´Ñ Èí¼ö Àå¾Ö¿¡ ÀÇÇÑ °ÍÀ¸·Î »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÈ´Ù. È© °ÇÁ¶¼Ò³»ÀÇ ³¿»õ¿Í ºñ½ÁÇÑ Æ¯À¯ÇÑ ³¿»õ¸¦ ³»¸ç, À̰ÍÀº Èí¼öµÇÁö ¾ÊÀº ¸ÞŸÀÌ¿À´Ñ¿¡ ´ëÇÑ ¼¼±ÕÀÇ ÀÛ¿ë¿¡ ÀÇÇÏ¿© Á¶¼ºµÇ´Â ¾ËÆÄ ÇÏÀ̵å·Ï½Ã ³«»êÀÌ ¿øÀÎÀÌ´Ù.

    Smith's dis

    ½º¹Ì½º º´
  • Soederland's disease
    Á¦µ¥¸¦¶õµå º´
    »ïÃ⼺ ¹æ±¤¿°À» ¸»Çϴµ¥, ¹«±Õ ³ó´¢º´À̶ó°íµµ ÇÑ´Ù.
  • spirochetal disease
    ½ºÇÇ·ÎÇìŸ Áúȯ
  • sporadic disease
    »ê¹ß Áúȯ, »ê¹ß¼º Áúȯ
  • sterility disease
    ºÒÀÓ¼º Áúȯ
  • Still's disease
    ½ºÆ¿ Áúȯ, ½ºÆ¿ º´
    µ¿ÀǾî=juvenile rheumatoid arthritis. 1. Ç÷û¿¡ ÀÌ»óÀÌ ³ªÅ¸³ªÁö ¾Ê´Â °üÀý¿°À¸·Î¼­ Á¾Á¾ ¹ß¿­°ú ¸²ÇÁÀýº´ÁõÀÌ µ¿¹ÝµÇ¸ç 16¼¼ ÀÌÀü¿¡ ½ÃÀÛÇÏ´Â °üÀý¿°ÀÇ 70%¸¦ Â÷ÁöÇÑ´Ù. 2. ¼Ò¾Æ¼º ¸²ÇÁÁ¾ ºñÁ¾¼º À§Ãà ´Ù¹ß¼º °üÀý¿°. ¼Ò¾Æ¿¡ »ý±â´Â ¸¸¼º ´Ù¹ß¼º °üÀý¿°ÀÇ ÀÏÁ¾. ¸²ÇÁÀý Á¾Ã¢, ºñÁ¾, ºÒ±ÔÄ¢¼º ¹ß¿­ÀÌ Æ¯Â¡ÀÌ´Ù.
  • storage pool disease
    ÀúÀåÁ¶º´
    ÀÀÁýÁ¦, ¿¡Çdz×ÇÁ¸°, ¿ÜÀμº ADP, Æ®·Òºó µî¿¡ ¹ÝÀÀÇÏ¿© ADP¸¦ ¹æÃâÇÏ´Â Ç÷¼ÒÆÇ ±â´É ºÎÀü¿¡ ÀÇÇÑ Ç÷¾× ÀÀ°í Àå¾Ö, °¡º­¿î ÃâÇ÷ Áõ»ó, ÃâÇ÷ ½Ã°£ Áö¿¬, ±³¿øÁúÀ̳ª Æ®·Òºó¿¡ ´ëÇÑ ÀÀÁý ¹ÝÀÀÀÇ °¨Å𸦠Ư¡À¸·Î ÇÑ´Ù.
  • stripe disease
    ¼±Á¶º´
  • strumpell's disease Ãø»è °æÈ­ÁõÀÇ À¯ÀüÇüÀ¸·Î ÀÌ Áúº´¿¡¼­ÀÇ °æ·ÃÀº ÁÖ·Î ¹ß¿¡ ÇÑÁ¤µÇ¾î ÀϾ´Ù.

    strychnine

    ½ºÆ®¸®Å©´Ñ
    ±Øµµ·Î µ¶¼ºÀÌ °­ÇÑ ¾ËÄ®·ÎÀ̵å. ÁÖ·Î Strychnos nuxvomica ¹× StrychnosÀÇ ´Ù¸¥ Á¾¿¡¼­ ¾ò¾îÁö¸ç, ½Å°æ Ãæµ¿ÀÇ Á¢ÇպΠÈĺÎÀÇ ¾ïÁ¦¸¦ Â÷´ÜÇÔÀ¸·Î½á ÁßÃß ½Å°æ°èÀÇ ¸ðµç ºÎºÐÀ» ÈïºÐ½ÃŲ´Ù. ÁßÃß ½Å°æ°èÀÇ ÈïºÐÁ¦·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌÀü¿¡´Â °í¹Ì °­ÀåÁ¦, ¼øÈ¯ ÀÚ±ØÁ¦·Î ¶Ç´Â ¼³»çÁ¦¿Í ¾Æ¿ï·¯ »ç¿ëµÇ¾ú´Ù.
  • subacute disease
    ¾Æ±Þ¼º Áúȯ
  • systemic degenerative joint disease
    Àü½Å¼º ÅðÇ༺ °üÀý Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
Carrion's disease A generalised, acute, febrile, endemic, and systemic form of bartonellosis; marked by high fever, rheumatic pains, progressive, severe anaemia, and albuminuria.
Synonym: Carrion's disease.
(05 Mar 2000)
gestational trophoblastic disease (choriocarcinoma, molar pregnancy) a type of cancer associated with pregnancy in which a grape-like mole develops in the womb instead of a foetus.
(16 Dec 1997)
parkinson disease Progressive, degenerative disease of unknown aetiology characterised by rhythmic tremor of the limbs, stooped posture, slowness of voluntary movements, and masklike facial expression. Pathologically there is nerve cell loss in the melanin-containing cells in the brainstem and a corresponding reduction in dopamine levels in the corpus striatum. Lewy bodies are present in the substantia nigra and locus coeruleus.
(12 Dec 1998)
parkinson disease, postencephalitic A form of parkinson disease due to degeneration of the corpus striatum or substantia nigra, frequently occurring as a sequel of lethargic encephalitis. The early age of onset, the rapid progression of symptoms and signs of stabilization, and the presence of a variety of other neurological disorders (sociopathic behaviour, tics, spasms, oculogyric crises and other restricted motor disorders, breathing arrhythmias, hyperphagia, and bizarre movements, postures, and gaits) distinguish this disease from the one described by parkinson.
(12 Dec 1998)
parkinson disease, symptomatic Symptoms of parkinson disease induced by drugs, or following cerebral arteriosclerosis, brain tumour, or other central nervous system disorders except encephalitis, which is parkinson disease, postencephalitic.
(12 Dec 1998)
Parkinson's disease <neurology> A progressive, neurological disease first described in 1817 by James Parkinson.
The pathology is not completely understood, but there appears to be consistent changes in the melanin-containing nerve cells in the brainstem (substantia nigra, locus coeruleus), where there are varying degrees of nerve cell loss with reactive gliosis along with eosinophilic intracytoplasmic inclusions (Lewy bodies). Biochemical studies have shown below normal levels of dopamine in the caudate nucleus and putamen.
Symptoms include shuffling gait, stooped posture, resting tremor, speech impediments, movement difficulties and an eventual slowing of mental processes and dementia.
(27 Sep 1997)
parrot disease <chest medicine, disease> Psittacosis is primarily an infectious disease of birds caused by the bacterium Chlamydia psittaci. Transmission from infected birds results in a relatively rare febrile illness characterised by pneumonia and systemic symptoms. A flu-like illness can also occur. Almost any bird can harbor this bacterium in their excreta, tissues, feathers and secretions, but parrots, parakeets and budgerigars are the most common. Psittacosis is considered an occupational disease of pet shop owners. Psittacosis is almost always transmitted to humans by the respiratory route. Average incubation is 7-14 days.
(27 Sep 1997)
Parrot's disease Pseudoparalysis in infants, due to syphilitic osteochondritis.
Synonym: marasmus.
(05 Mar 2000)
parry's disease Toxic multinodular goiter. Named for the english physician caleb hillier parry (1755-1822). Also called plummer's disease.
(12 Dec 1998)
Gierke's disease Glycogenosis due to glucose-6-phosphatase deficiency, resulting in accumulation of excessive amounts of glycogen of normal chemical structure, particularly in liver and kidney.
Synonym: Gierke's disease, glucose-6-phosphatase hepatorenal glycogenosis, von Gierke's disease.
(05 Mar 2000)
castleman disease <radiology> Angiofollicular lymph node hyperplasia, benign lymphoid hyperplasia, massively enlarged lymph nodes, mediastinum most common; rarely in mesentery, age less than 30 yrs, types: hyaline vascular (90%), asymptomatic, vascular proliferation and hyalinization, plasma cell (10%), fever, anaemia, increased sed rate, increased IgG
(12 Dec 1998)
Castleman's disease Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma.
Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease.
(05 Mar 2000)
gilbert's disease A benign familial disorder, transmitted as an autosomal dominant trait. It is characterised by low-grade chronic hyperbilirubinaemia with considerable daily fluctuations of the bilirubin level.
(12 Dec 1998)
Gilchrist's disease <disease> A fungal infection caused by Blastomyces dermatitidis. This rare fungal infection may produce inflammatory lesion of the skin or lungs or present as a disseminated disease to the skin, lungs, bones, liver, spleen and central nervous system. Uncommon unless patient is immunocompromised (AIDS).
(27 Sep 1997)
Gilles de la Tourette's disease <syndrome> Both multiple motor and one or more vocal tics present with tics occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a general medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (dsm-IV, 1994)
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á